MedTrace Logo

Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases

NCT01410370 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2013-04-24

No results posted yet for this study

Summary

The aim of this study is to evaluate the clinical efficacy and safety of continuous Endostar infusion combined with radiotherapy for treatment of brain metastases.

Conditions

Interventions

RADIATION

6MV-X ray

3Gy/time, 5 times/week, a total of 10 times

DRUG

Endostar

7.5mg/m2/d, continuous infusion, in parallel with radiotherapy

Sponsors & Collaborators

  • The First People's Hospital of Lianyungang

    collaborator OTHER

  • Jiangsu Simcere Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Xiaodong Jiang, MD · The First People's Hospital of Lianyungang

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01410370 on ClinicalTrials.gov